Study on efficacy and safety of levetiracetam administration by nasogastric tube in patients with convulsive status epilepticus
Not Applicable
- Conditions
- Convulsive status epilepticus
- Registration Number
- JPRN-UMIN000010552
- Lead Sponsor
- Department of Emergency and Critical Care Medicine, Wakayama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Patinets with non-convulsive status epilepticus Patients required administration of sedative with anticonvulsive effect Systolic blood pressure <60mmHg, >=220mmHg Heart rate <40/min, >=150/min Respiration rate <5/min, >=40/min SpO2 <89% Unstable state of airway Acute coronary syndrome Active gastrointestinal bleeding Patients required intermittent hemodialysis or continuous renal replacement therapy Levetiracetam allergy Patients considered as inappropriate to participate in this study by attending physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Disappearance of convulsion within 30 min after administration
- Secondary Outcome Measures
Name Time Method Seizure free period of 3-day after administration Side effects Mortality